Lenzing's Alabama Bet and the Heiligenkreuz Question Don't Answer the Same Test
Published on 11/20/2026 at 14:21 | Editorial boerse-global.deLenzing shares were down 2.9% in Friday morning trading, extending a retreat that began after Berenberg trimmed its price target on the specialty fibre maker from EUR 17.00 to EUR 13.50 a day earlier while keeping its "Hold" rating. By midday the decline had widened to 3.7%. The headline number tells only part of the story. What matters more for anyone weighing the equity is that two very different events are unfolding at once — a capacity expansion in the United States and an unresolved site question in Austria — and they cannot be judged by the same yardstick.
A writedown already baked into the numbers
Berenberg's reassessment carries a concrete charge: the broker has factored a EUR 136 million impairment for the Grimsby and Heiligenkreuz sites into its model. On that basis it projects earnings per share of minus EUR 4.04 for 2026. That figure is an estimate, not a reported annual result, and it describes the burden at two locations rather than a verdict on what Lenzing might earn from extra capacity elsewhere.
The distinction matters. A writedown embedded in an analyst's forecast is an accounting charge tied to specific assets. It says nothing about the return on a new investment in a different country, and the two should not be netted against each other.
Alabama points to where capital is heading
On 12 November Lenzing announced a EUR 27 million investment at its Mobile, Alabama facility, where it plans to add capacity for specialty fibres used in nonwovens, including lyocell short-cut fibres. The project sits inside a broader EUR 50 million programme aimed at the nonwovens business.
Should investors sell immediately? Or is it worth buying Lenzing?
That is not a blanket growth pledge. Lenzing has named a site and a specific end-use for the additional fibre — precisely what makes the announcement useful for framing the investment case. It shows where management intends to direct capital, even as the analyst estimate captures the drag from sites elsewhere.
The margin, not the top line, is the real test
Whether the nonwovens push actually strengthens operating profitability is a separate question from whether it happens. Extra capacity alone does not answer it. Only if the specialty fibres can be sold on adequate terms will the expansion feed through to earnings power; higher revenue on its own would not be sufficient evidence.
Lenzing's figures for the first nine months of 2026 offer a starting point: revenue of EUR 1.93 billion, adjusted EBITDA of EUR 353 million, and an adjusted EBITDA margin of 18.3%. That margin is a benchmark for later comparisons, not proof that the announced expansion will succeed — and the group-level figure cannot tell investors what Mobile might contribute in future.
Two scenarios, two different scorecards
The more favourable path requires Lenzing to secure a viable sale solution for Heiligenkreuz while the Mobile build-out leaves the adjusted margin unharmed. A sale would settle the open site question, but the second condition is the one that would actually matter for earnings prospects: the additional capacity would have to be economically usable. A stable or rising margin in later reports would be a positive signal for the group's earning power during the restructuring — though such a development could not simply be credited to Mobile.
Conversely, closing a deal at Heiligenkreuz would not by itself justify expecting a larger earnings contribution from the specialty fibre expansion. The two projects have to be measured against different outcomes.
What a margin squeeze would signal
In the less favourable scenario, no sale materialises and the extra Alabama capacity cannot be utilised on adequate terms. The adjusted margin could then give way even if Lenzing sells more specialty fibre. The mere fact that the investment has been announced says nothing about how utilisation and returns will develop.
Lenzing at a turning point? This analysis reveals what investors need to know now.
The EUR 136 million impairment for Heiligenkreuz and Grimsby belongs in this weighing too. It was cited as background to the target cut. It does not establish that Heiligenkreuz will be shut, nor how profitable the added Mobile capacity might be. For judging the ongoing business, a decline in the adjusted margin would be the more immediate warning signal.
A deadline before year-end
According to Der Standard, Lenzing is reviewing several non-binding purchase offers for Heiligenkreuz. By the end of 2026 it aims to establish whether a viable sale can be reached; failing that, closure is planned for the end of the first quarter of 2027. The offers are a possible route to a sale, not a completed transaction.
As long as the adjusted margin holds, an expansion without damage to operating profitability remains a plausible scenario. Should it weaken, investors would need to assume a more modest earnings contribution from Mobile — even if a solution is found for Heiligenkreuz. The clarity sought by year-end is the next fixed date on the site question. Whether the expansion strengthens earning power, by contrast, will have to show up in the business figures.
Ad
Lenzing Stock: New Analysis - 20 November
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
